An observational study in Primary Intramuscular Hydatid Cyst Hydatid Disease (Echinococcosis), sponsored by Al-Shahba Specialized Hospital. Completed at 1 site in Syria. Open to male participants aged 18 Years to 120 Years. Per ClinicalTrials.gov, last updated 2025-09-16.
Sponsored by Al-Shahba Specialized Hospital · Observational
This case report describes a rare parasitic cyst called a hydatid cyst located in the shoulder muscle (deltoid) of a 29-year-old male. The patient initially presented with a painless, gradually enlarging swelling over the left shoulder. It was misdiagnosed as a synovial cyst and treated with corticosteroids, which caused local inflammation and purulent discharge. Blood tests for Echinococcus antibodies were negative. Ultrasound and MRI revealed a well-defined intramuscular cyst confined to the deltoid muscle. Surgical excision confirmed the diagnosis, and the patient received postoperative albendazole therapy for three months. Follow-up showed complete healing, restoration of shoulder function, and no recurrence. This case highlights the importance of considering hydatid disease in unusual muscle locations, particularly in endemic areas, to avoid misdiagnosis and ensure proper treatment.
This report presents a rare case of a primary intramuscular hydatid cyst confined to the deltoid muscle in a 29-year-old male. The patient had a seven-month history of a gradually enlarging swelling in the left shoulder. Initially misdiagnosed as a synovial cyst, he received corticosteroid injection, which led to pain, erythema, and purulent discharge. Physical examination revealed a 10 cm fluctuant mass over the posterolateral deltoid. Serology for Echinococcus antibodies was negative. Ultrasound showed a well-defined, anechoic intramuscular cyst measuring 7 × 8 × 10 cm. MRI confirmed a fluid-filled cyst confined to the deltoid muscle, without involvement of bone, tendon, or joint structures. Under local anesthesia, the cyst was completely excised, and the cavity was irrigated with 10% povidone-iodine. Histopathology confirmed a non-fertile hydatid cyst (Echinococcus granulosus) without malignancy. Postoperative therapy included albendazole 400 mg daily for three months. Follow-up at six weeks showed complete wound healing, full shoulder function, and no recurrence. This case underscores the diagnostic challenges of intramuscular hydatid cysts, especially with negative serology, and highlights the importance of imaging, histopathology, and careful surgical management in endemic regions.
32 studies on the registry are indexed under Echinococcosis; 5 are open to participants now.
This study's enrollment of 1 is below the median of 86 across 20 observational studies indexed under Echinococcosis.
Browse Echinococcosis studies →This is the only study on the registry with Al-Shahba Specialized Hospital as lead sponsor.
Counted across the registry records on this site, refreshed daily.
A single 29-year-old male patient diagnosed with primary intramuscular hydatid cyst of the deltoid muscle. The patient underwent surgical excision and postoperative albendazole therapy.
Male patient Age 18 years or older Diagnosed with primary intramuscular hydatid cyst of the deltoid muscle
Exclusion Criteria:
Patients with cysts in other organs (liver, lungs) Patients with systemic infection or immunocompromised status Patients who did not undergo surgical excision
-
Complete recovery of shoulder function without recurrence
Monitoring for surgical site infection, serological status, and general patient well-being following treatment.
Time frame: 6 weeks postoperatively
This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.